Literature DB >> 17680801

Prostaglandin E2 modulates dendritic cell function during chlamydial genital infection.

Wei Liu1, Kathleen Ann Kelly.   

Abstract

Inflammatory responses mediated by antigen-presenting dendritic cells (DCs), can be modulated by the presence of prostaglandins (PG), including prostaglandin E2 (PGE2). PGE2 modifies the production of an immune response by altering DC function through PGE2 receptors. PGE2 is produced by epithelial cells lining the murine female reproductive tract during Chlamydia muridarum infection and likely manipulates the antichlamydial immune response during antigen uptake in the genital mucosa. Our data demonstrate that the PGE2 present locally in the genital tract upon chlamydial genital infection enhanced the recruitment of CD11b+ conventional DCs, but not CD45R+ plasmacytoid DCs, to infected genital tract tissue and draining lymph nodes in vivo. Furthermore, exposure to PGE2 in vitro during infection of murine bone-marrow-derived conventional DCs (cDCs) boosted interleukin-10 mRNA and protein while not influencing interleukin-12p40 production. Infection of cDCs markedly increased mRNA production of the costimulatory molecules CD86, CD40 and a member of the C-type lectin family, DEC-205, but addition of PGE2 increased other costimulatory molecules and C-type lectins. Also, exposure of PGE2 to infected cDCs increased FcgammaRIII and FcgammaRIIb, suggesting that PGE2 enhances the uptake and presentation of C. muridarum and augments production of the antichlamydial adaptive immune response. Taken together, the data suggest that exposure of infected cDCs to PGE2 drives production of a diverse adaptive immune response with implications for regulating tissue inflammation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17680801      PMCID: PMC2433296          DOI: 10.1111/j.1365-2567.2007.02642.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  76 in total

Review 1.  Immunobiology of dendritic cells.

Authors:  J Banchereau; F Briere; C Caux; J Davoust; S Lebecque; Y J Liu; B Pulendran; K Palucka
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway.

Authors:  A Joss; M Akdis; A Faith; K Blaser; C A Akdis
Journal:  Eur J Immunol       Date:  2000-06       Impact factor: 5.532

Review 3.  Dendritic cells: specialized and regulated antigen processing machines.

Authors:  I Mellman; R M Steinman
Journal:  Cell       Date:  2001-08-10       Impact factor: 41.582

4.  Expression of genes encoding Th1 cell-activating cytokines and lymphoid homing chemokines by chlamydia-pulsed dendritic cells correlates with protective immunizing efficacy.

Authors:  J H Shaw; V R Grund; L Durling; H D Caldwell
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

Review 5.  Interleukin-10 and the interleukin-10 receptor.

Authors:  K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

6.  Prostaglandin E(2) is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer.

Authors:  P Kaliński; P L Vieira; J H Schuitemaker; E C de Jong; M L Kapsenberg
Journal:  Blood       Date:  2001-06-01       Impact factor: 22.113

7.  Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells.

Authors:  S G Morrison; H Su; H D Caldwell; R P Morrison
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

8.  Early local cytokine profiles in strains of mice with different outcomes from chlamydial genital tract infection.

Authors:  T Darville; C W Andrews; J D Sikes; P L Fraley; R G Rank
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

9.  IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells.

Authors:  M K Levings; R Sangregorio; F Galbiati; S Squadrone; R de Waal Malefyt; M G Roncarolo
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

10.  CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells.

Authors:  H Nakano; M Yanagita; M D Gunn
Journal:  J Exp Med       Date:  2001-10-15       Impact factor: 14.307

View more
  7 in total

Review 1.  Monocyte-derived DC maturation strategies and related pathways: a transcriptional view.

Authors:  Luciano Castiello; Marianna Sabatino; Ping Jin; Carol Clayberger; Francesco M Marincola; Alan M Krensky; David F Stroncek
Journal:  Cancer Immunol Immunother       Date:  2011-01-22       Impact factor: 6.968

2.  Human conjunctival transcriptome analysis reveals the prominence of innate defense in Chlamydia trachomatis infection.

Authors:  Angels Natividad; Tom C Freeman; David Jeffries; Matthew J Burton; David C W Mabey; Robin L Bailey; Martin J Holland
Journal:  Infect Immun       Date:  2010-09-07       Impact factor: 3.441

Review 3.  Dendritic cells and macrophages in the genitourinary tract.

Authors:  N Iijima; J M Thompson; A Iwasaki
Journal:  Mucosal Immunol       Date:  2008-09-10       Impact factor: 7.313

4.  Targeting vault nanoparticles to specific cell surface receptors.

Authors:  Valerie A Kickhoefer; Muri Han; Sujna Raval-Fernandes; Michael J Poderycki; Raymond J Moniz; Dana Vaccari; Mariena Silvestry; Phoebe L Stewart; Kathleen A Kelly; Leonard H Rome
Journal:  ACS Nano       Date:  2009-01-27       Impact factor: 15.881

5.  Identification of dendritic cell subsets responding to genital infection by Chlamydia muridarum.

Authors:  Raymond J Moniz; Ann M Chan; Kathleen A Kelly
Journal:  FEMS Immunol Med Microbiol       Date:  2009-01-12

6.  A bovine model of respiratory Chlamydia psittaci infection: challenge dose titration.

Authors:  Petra Reinhold; Carola Ostermann; Elisabeth Liebler-Tenorio; Angela Berndt; Anette Vogel; Jacqueline Lambertz; Michael Rothe; Anke Rüttger; Evelyn Schubert; Konrad Sachse
Journal:  PLoS One       Date:  2012-01-27       Impact factor: 3.240

7.  A vault nanoparticle vaccine induces protective mucosal immunity.

Authors:  Cheryl I Champion; Valerie A Kickhoefer; Guangchao Liu; Raymond J Moniz; Amanda S Freed; Liisa L Bergmann; Dana Vaccari; Sujna Raval-Fernandes; Ann M Chan; Leonard H Rome; Kathleen A Kelly
Journal:  PLoS One       Date:  2009-04-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.